Page last updated: 2024-08-21

vancomycin and virginiamycin

vancomycin has been researched along with virginiamycin in 146 studies

Research

Studies (146)

TimeframeStudies, this research(%)All Research%
pre-19908 (5.48)18.7374
1990's68 (46.58)18.2507
2000's51 (34.93)29.6817
2010's17 (11.64)24.3611
2020's2 (1.37)2.80

Authors

AuthorsStudies
Avril, JL; Lissac, J1
Appelbaum, PC; Jacobs, MR; Spangler, SK1
Nishino, T1
Baillie, L; Casewell, M; Rolando, N; Wade, J1
Chambers, HF1
Goto, S; Kaneko, Y; Miyazaki, S1
Verbist, L; Verhaegen, J1
Bouanchaud, DH; Huet, Y; Rolin, O1
Maskell, JP; Williams, JD1
Cancet, B; Clave, D; Didier, J; Henry-Ferry, S; Marty, N1
Chi, SJ; Maskell, JP; Sefton, AM; Williams, JD; Yong, J1
Beck, D; Siegenthaler, G; Siegenthaler, W; Weidmann, P1
Hohenegger, M; Hromadka, A1
Lecaillon-Thibon, E; Messmer, JC; Soler, H1
Drugeon, H; Entenza, JM; Glauser, MP; Moreillon, P1
Entenza, JM; Glauser, MP; L'Hériteau, F; Lacassin, F; Leport, C; Moreillon, P1
Kang, SL; Rybak, MJ2
Carbon, C; Duval, J; Fantin, B; Leclercq, R; Merlé, Y; Saint-Julien, L; Veyrat, C1
Cooper, B; Freeman, C; Mazens-Sullivan, M; Nightingale, C; Quintiliani, R; Robinson, A1
Appelbaum, PC; Jacobs, MR; Pankuch, GA2
Carbon, C; Duval, J; Fantin, B; Leclercq, R; Maziere, B; Ottaviani, M; Pocidalo, JJ; Vallois, JM1
Collins, LA; Eliopoulos, GM; Ferraro, MJ; Malanoski, GJ; Moellering, RC; Wennersten, CB1
Berthaud, N; Conard, BJ; Desnottes, JF; Montay, G1
Millichap, J; Noskin, GA; Peterson, LR; Ristow, TA1
Herrera-Insúa, I; Jacques-Palaz, K; Murray, BE; Rakita, RM1
Zervos, M1
Furness, KM; Holloway, WJ; Johnson, JA; Johnson, RJ; McIntosh, AC; Qaiyumi, S; Schwalbe, RS; Steele-Moore, L1
Cormican, MG; Johnson, DM; Jones, RN1
Chow, JW; Donahedian, SM; Zervos, MJ1
Chow, JW; Davidson, A; Sanford, E; Zervos, MJ1
Garcia, R; Raad, I1
Handwerger, S; Mildvan, D; Shonekan, D1
Bradley, JS; Scheld, WM1
Mariano, N; Rahal, JJ; Sahgal, VS; Turner, J; Urban, C; Weinbaum, F1
Noskin, GA; Peterson, LR; Ristow, TA; Warren, JR1
Dejesus, D; Dever, LL; Johanson, WG; Kaminski, ZC; Masurekar, M; Patel, D; Smith, SM1
Dever, LL; Handwerger, S1
Deobaldia, J; Evans, PA; Norden, CW; Rhoads, S; Silber, JL1
Furlong, WB; Rakowski, TA1
Bates, J; Chadwick, PR; Johnson, AP; Palepou, MF; Woodford, N1
Hardin, TC; Harkless, LB; Reyzelman, AM; Van Gils, CC; Vayser, DJ1
London, NH; Mertens, P; Stobberingh, EE; van den Bogaard, AE1
Messick, CR; Pendland, SL1
Caron, F; Eliopoulos, GM; Farris, MG; Gold, HS; Moellering, RC; Wennersten, CB1
Tuohy, M; Washington, JA1
Casewell, MW; Hill, RL; Seyed-Akhavani, M; Smith, CT1
Maskell, JP; Sefton, AM; Whiley, AC; Williams, JD1
Fernandes, F; Lorian, V2
Berthaud, N; Desnottes, JF; Diallo, N; Huet, Y1
Kramer, DJ; Linden, PK; McDevitt, D; Pasculle, AW1
Fluit, A; Heinz, HP; Jones, ME; Schmitz, FJ; Verhoef, J1
Cerwinka, S; Dowzicky, M; Eliopoulos, GM; Farris, MG; Gold, HS; Moellering, RC; Nadler, HL; Schülin, T; Souli, M; Talbot, GH; Wennersten, CB1
Busciglio, L; Fontanet, H; Gamouras, G; Larkin, J1
Huneycutt, S; Phillips, A; Tush, GM; Ward, JD1
Bompart, F; Dowzicky, M; Feger, C; Nadler, HL; Pease, M; Talbot, G1
Aeschlimann, JR; Rybak, MJ1
Aeschlimann, JR; Rybak, MJ; Zervos, MJ1
Klare, I; Werner, G; Witte, W1
Messick, CR; Pendland, SL; Woodward, J1
Matsumura, S; Simor, AE1
Heisig, P; Jones, ME; Klootwijk, M; Schmitz, FJ; Verhoef, J; Visser, MR1
Cohen, MA; Huband, MD1
Aeschlimann, JR; Hershberger, E; Moldovan, T; Rybak, MJ1
Brown, GH; Rotschafer, JC; Wright, DH1
Bompart, F; Hachem, R; Raad, I1
Andrews, J; Ashby, J; Jevons, G; Lines, N; Wise, R1
Hayashi, M; Higashitsutsumi, M; Igari, J; Inamatsu, T; Inoue, M; Kaku, M; Kanno, H; Kawai, T; Kobayashi, Y; Kohno, S; Kubo, S; Miyazaki, S; Oguri, T; Saito, A; Sakamoto, M; Shiba, K; Shimada, J; Shimizu, Y; Tokue, Y; Tomono, K; Ubukata, K; Ueda, Y; Watanabe, A; Yamaguchi, K1
Barriere, SL; Dunn, DL; Graham, DR; Kreter, B; Nichols, RL; Rodgers, A; Wilson, SE; Zervos, M1
Bozdogan, B; Leclercq, R; Lozniewski, A; Weber, M1
Péchère, JC1
Louie, L; Louie, M; Matsumura, SO; Simor, AE1
Messick, CR; Pendland, SL; Rodvold, KA1
Anholm, JD; Cheadle, WG; Fabian, TC; Fagon, J; Falcone, RE; Gibert, C; Haas, DW; Lilienthal, F; Paganin, F; Patrick, H; Torres, A1
Grucz, RG; Hershberger, E; Moldovan, T; Rybak, MJ1
Lundstrom, TS; Sobel, JD2
Barry, AL; Brown, SD; Fuchs, PC2
Flanagan, PG; Penrose-Stevens, A; Pitman, I; Simpson, BA; Tan, TY1
Chin, KG; Mactal-Haaf, C; McPherson, CE1
Murray, BE; Robredo, B; Singh, KV; Torres, C1
Foustoukou, M; Ioannidou, S; Kotsovili-Tseleni, A; Legakis, NJ; Tassios, PT; Vatopoulos, A1
Duh, RW; Malathum, K; Murray, BE; Singh, KV1
Cortés Sanchez, R; García Alberola, A; Gómez Gómez, J; López Fornas, F; Martínez García, F; Pérez Salmeron, J; Roldán Conesa, D; Ruíz Gómez, J; Valdés Chávarri, M1
Longworth, DL1
Carr, LE; English, LL; Hayes, JR; Joseph, SW; Wagner, DD1
Ferber, D1
Ameur, N; Bléton, R; Crémieux, AC; Feger, C; Ismael, F; Lemaitre, F; Massias, L; Muller-Serieys, C; Saleh-Mghir, A1
Cadrobbi, P; Cattelan, A; Cusinato, R; Gambino, A; Meneghetti, F; Narne, E; Scano, F; Sgarabotto, D; Zignol, M1
Saxén, H; Vaara, M1
Bassetti, D; Bassetti, M; Cenderello, G; Di Biagio, A; Melica, G; Rosso, R1
Rigoli, R; Scotton, PG; Vaglia, A1
García-Rodríguez, JA; Gutiérrez Zufiaurre, MN; Muñoz Bellido, JL; Sánchez Hernández, FJ; Segovia Hernández, M; Yagüe Guirao, G1
Abb, J1
Chau, F; Fantin, B; Garry, L; Leclercq, R; Lefort, A; Pavie, J; Zarrouk, V1
Moyenuddin, M; Ohl, CA; Peacock, JE; Williamson, JC1
Citron, DM; Fernandez, HT; Goldstein, EJ; Merriam, CV; Tyrrell, KL; Warren, YA1
Chatzidimitriou, M; Katikaridou, E; Kollaras, P; Koumentaki, E; Metallidis, S; Nikolaidis, P; Tourkantonis, A; Tsona, A1
Agamah, E; Goodrich, J; Kanchanapoom, T; Khardori, N; Koirala, J1
Clark, NM; Hershberger, E; Lynch, JP; Zervosc, MJ1
Andersen, JS; Emborg, HD; Seyfarth, AM; Wegener, HC1
Athamna, A; Athamna, M; Bast, DJ; Medlej, B; Rubinstein, E1
Ahearn, DG; Halliman, DG1
Fougnot, S; Lozniewski, A; Mory, F; Rabaud, C; Schuhmacher, H1
El-Azizi, M; Kanchanapoom, T; Khardori, N; Rao, S1
Buckley, T; Chapin, A; Gibson, K; Rule, A; Schwab, K1
Cirioni, O; De Fusco, M; Ghiselli, R; Giacometti, A; Licci, A; Mocchegiani, F; Orlando, F; Provinciali, M; Saba, V; Scalise, G; Silvestri, C1
Heo, ST; Ki, HK; Kiem, S; Ko, KS; Lee, JY; Moon, CS; Oh, WS; Peck, KR; Song, JH1
Fraser, TG; Hansen, C; Long, JK1
Chaudhury, A; Kumar, AG1
Flynn, HW; Harper, T; Miller, D1
Manfredi, R1
Chambers, HF; Hegde, SS1
Hur, JA; Kang, MW; Kim, SI; Kim, YJ; Kim, YR; Park, YJ; Wie, SH1
Batard, E; Caillon, J; Hamel, A; Jacqueline, C; Potel, G1
Anstead, GM; Lewis, JS; Quinones-Nazario, G1
De Vecchi, E; Drago, L; Nicola, L1
Bhateja, P; Bhatnagar, PK; Fatma, T; Khan, S; Mathur, T; Pandya, M; Rattan, A; Singhal, S; Upadhyay, DJ1
Manzur, A; Pujol, M; Suárez, C; Tubau, F1
Adochitei, A; Duez, JM; Neuwirth, C; Péchinot, A; Siebor, E; Sixt, N1
Alexandre, SS; Huang, V; McGowan, JE; Segal, RE; Sinner, SW; Tenover, FC; Weinstein, MP1
Ermertcan, S; Gülden, E1
Appelbaum, PC; Beachel, L; Clark, C; Dewasse, B; Kosowska-Shick, K; McGhee, P; Pankuch, GA1
Nailor, MD; Sobel, JD1
Janechek, MJ; Jones, RN; Mendes, RE; Moet, GJ1
Cheung, CM; Leuthner, KD; Rybak, MJ; Vidaillac, C1
Adali, F; Asan, A; Baltalarli, A; Cevahir, N; Kaleli, I; Onem, G; Sacar, M; Sacar, S; Susam, I; Teke, Z; Turgut, H; Yaylali, YT1
Sancak, B1
Aslantas, Ö; Demir, C; Erdem, Z; Türkyilmaz, S; Yilmaz, MA1
Arslan, U; Aydın, F; Bayramoğlu, G; Baysan, BO; Berktaş, M; Cesur, S; Cöplü, N; Demiröz, AP; Esen, B; Gencer, S; Gülay, Z; Hoşoğlu, S; Irmak, H; Karabiber, N; Kılıç, H; Simşek, H; Yalçın, AN1
Biavasco, F; Donelli, G; Pasquaroli, S; Vignaroli, C; Vuotto, C; Zandri, G1
Muscedere, J1
Hsu, AJ; Tamma, PD1
Gallagher, JC; Patel, R1
Behl, P; Chander, J; Gupta, V; Sahoo, T; Singla, N1
Bartolomeu, AR; Brito, CI; Camargo, CH; Cunha, ML; Oliveira, A; Pereira, VC; Pinheiro, L1
Ahn, JW; Baek, YS; Jeon, J; Song, HJ1
Hao, Y; Mao, R; Teng, D; Wang, J; Wang, X; Yang, N; Zong, L1
Chen, Z; Guo, Y; Li, D; Lv, J; Qi, X; Wang, L; Wang, S; Yu, F; Zhang, X1
Rybak, MJ; Smith, JR; Yim, J1
Biavasco, F; Citterio, B; Mangiaterra, G; Pasquaroli, S; Vignaroli, C1
Karahan, ZC; Ozmen Capin, BB; Tekeli, A1
Chen, YH; Chen, YS; Cheng, SH; Hsueh, PR; Ko, WC; Lee, CM; Lee, WS; Lee, YL; Liao, CH; Lin, CY; Liu, CP; Liu, PY; Lu, MC; Lu, PL; Shao, PL; Sheng, WH; Shi, ZY; Tsai, HY; Tseng, SH; Wang, FD; Wang, LS; Wu, TS; Yen, MY1

Reviews

23 review(s) available for vancomycin and virginiamycin

ArticleYear
[Synergistins, vancomycin and polymyxins].
    La Revue du praticien, 1977, Oct-11, Volume: 27, Issue:45

    Topics: Anti-Bacterial Agents; Humans; Polymyxins; Vancomycin; Virginiamycin

1977
[Recent trend and development of novel antimicrobial agents for MRSA infections].
    Nihon rinsho. Japanese journal of clinical medicine, 1992, Volume: 50, Issue:5

    Topics: Daptomycin; Glycopeptides; Humans; Methicillin Resistance; Peptides; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin; Virginiamycin

1992
Vancomycin-resistant Enterococcus faecium infections in the ICU and quinupristin/dalfopristin.
    New horizons (Baltimore, Md.), 1996, Volume: 4, Issue:3

    Topics: Drug Resistance, Microbial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Vancomycin; Virginiamycin

1996
The challenge of penicillin-resistant Streptococcus pneumoniae meningitis: current antibiotic therapy in the 1990s.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1997, Volume: 24 Suppl 2

    Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Child; Child, Preschool; Chloramphenicol; Clindamycin; Female; Fluoroquinolones; Humans; Infant; Infant, Newborn; Lactams; Male; Meningitis, Bacterial; Naphthyridines; Penicillin Resistance; Rifampin; Streptococcal Infections; Streptococcus pneumoniae; Vancomycin; Virginiamycin

1997
Evaluation of in vitro activity of quinupristin/dalfopristin and comparator antimicrobial agents against worldwide clinical trial and other laboratory isolates.
    The American journal of medicine, 1998, May-29, Volume: 104, Issue:5A

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Clinical Trials, Phase III as Topic; Drug Resistance, Multiple; Enterococcus faecium; Gram-Positive Bacteria; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus epidermidis; Vancomycin; Virginiamycin

1998
Gram-positive infections: pharmacy issues and strategy for quinupristin/dalfopristin.
    Diagnostic microbiology and infectious disease, 1999, Volume: 33, Issue:2

    Topics: Anti-Bacterial Agents; Humans; Vancomycin; Virginiamycin

1999
Current and future management of infections due to methicillin-resistant staphylococci infections: the role of quinupristin/dalfopristin.
    The Journal of antimicrobial chemotherapy, 1999, Volume: 44 Suppl A

    Topics: Anti-Bacterial Agents; Bacteremia; Humans; Methicillin Resistance; Staphylococcal Infections; Vancomycin; Virginiamycin

1999
Antibiotics for gram-positive bacterial infections. Vancomycin, teicoplanin, quinupristin/dalfopristin, and linezolid.
    Infectious disease clinics of North America, 2000, Volume: 14, Issue:2

    Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Microbial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazoles; Oxazolidinones; Teicoplanin; Vancomycin; Virginiamycin

2000
Use of anti-infective agents during lactation: Part 1--Beta-lactam antibiotics, vancomycin, quinupristin-dalfopristin, and linezolid.
    Journal of human lactation : official journal of International Lactation Consultant Association, 2000, Volume: 16, Issue:4

    Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Drug Therapy, Combination; Female; Humans; Lactation; Linezolid; Milk, Human; Mothers; Oxazolidinones; Vancomycin; Virginiamycin

2000
Microbial drug resistance and the roles of the new antibiotics.
    Cleveland Clinic journal of medicine, 2001, Volume: 68, Issue:6

    Topics: Acetamides; Anti-Infective Agents; Atovaquone; Aza Compounds; Drug Combinations; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus; Fluoroquinolones; Gatifloxacin; Humans; Linezolid; Methicillin Resistance; Moxifloxacin; Naphthoquinones; Oxazolidinones; Proguanil; Pseudomonas aeruginosa; Quinolines; Staphylococcus aureus; Streptococcus pneumoniae; Vancomycin; Vancomycin Resistance; Virginiamycin

2001
[New antibacterial agents].
    Duodecim; laaketieteellinen aikakauskirja, 1999, Volume: 115, Issue:20

    Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Daptomycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Fluoroquinolones; Humans; Oxazolidinones; Protein Synthesis Inhibitors; Vancomycin; Virginiamycin

1999
Gram-positive bacterial resistance. A challenge for the next millennium.
    Panminerva medica, 2002, Volume: 44, Issue:3

    Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus; Gram-Positive Bacteria; Humans; Linezolid; Oxazolidinones; Staphylococcus aureus; Vancomycin; Virginiamycin

2002
Antimicrobial resistance among gram-positive organisms in the intensive care unit.
    Current opinion in critical care, 2003, Volume: 9, Issue:5

    Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Community-Acquired Infections; Drug Resistance, Microbial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Linezolid; Methicillin Resistance; Oxazolidinones; Staphylococcus aureus; Treatment Outcome; United States; Vancomycin; Virginiamycin

2003
Antibiotics for gram-positive bacterial infections: vancomycin, quinupristin-dalfopristin, linezolid, and daptomycin.
    Infectious disease clinics of North America, 2004, Volume: 18, Issue:3

    Topics: Anti-Bacterial Agents; Daptomycin; Gram-Positive Bacterial Infections; Humans; Vancomycin; Virginiamycin

2004
Newer antibiotics for serious gram-positive infections.
    Cleveland Clinic journal of medicine, 2006, Volume: 73, Issue:9

    Topics: Acute Disease; Adolescent; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; Middle Aged; Vancomycin; Virginiamycin

2006
[Therapeutic perspectives of linezolid in the management of infections due to multiresistant Gram-positive pathogens].
    Recenti progressi in medicina, 2007, Volume: 98, Issue:3

    Topics: Acetamides; Administration, Oral; Anti-Infective Agents; Daptomycin; Drug Resistance, Multiple, Bacterial; Enterococcus; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Injections, Intravenous; Linezolid; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Practice Guidelines as Topic; Staphylococcus aureus; Streptococcus pneumoniae; Teicoplanin; Tigecycline; Time Factors; Vancomycin; Virginiamycin

2007
Combating the growing problem of methicillin-resistant Staphylococcus aureus: do the newer antibiotics represent a better alternative to vancomycin?
    Expert review of anti-infective therapy, 2007, Volume: 5, Issue:3

    Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Linezolid; Methicillin Resistance; Minocycline; Oxazolidinones; Staphylococcus aureus; Tigecycline; Vancomycin; Virginiamycin

2007
Treatment of infections caused by resistant Staphylococcus aureus.
    Methods in molecular biology (Clifton, N.J.), 2007, Volume: 391

    Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Humans; Linezolid; Methicillin Resistance; Minocycline; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Tigecycline; Vancomycin; Virginiamycin

2007
Antibiotics for gram-positive bacterial infections: vancomycin, teicoplanin, quinupristin/dalfopristin, oxazolidinones, daptomycin, dalbavancin, and telavancin.
    Infectious disease clinics of North America, 2009, Volume: 23, Issue:4

    Topics: Aminoglycosides; Anti-Bacterial Agents; Daptomycin; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Peptides, Cyclic; Teicoplanin; Vancomycin; Virginiamycin

2009
[Staphylococcus aureus and antibiotic resistance].
    Mikrobiyoloji bulteni, 2011, Volume: 45, Issue:3

    Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Minocycline; Oxazolidinones; Protein Synthesis Inhibitors; Staphylococcal Infections; Teicoplanin; Tigecycline; Vancomycin; Vancomycin Resistance; Virginiamycin

2011
Optimizing therapy for vancomycin-resistant enterococcal bacteremia in children.
    Current opinion in infectious diseases, 2014, Volume: 27, Issue:6

    Topics: Acetamides; Adolescent; Child; Child, Preschool; Daptomycin; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Risk Factors; Treatment Outcome; Vancomycin; Vancomycin-Resistant Enterococci; Virginiamycin

2014
Vancomycin-resistant enterococcal bacteremia pharmacotherapy.
    The Annals of pharmacotherapy, 2015, Volume: 49, Issue:1

    Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Daptomycin; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Vancomycin; Vancomycin-Resistant Enterococci; Virginiamycin

2015
Role of Combination Antimicrobial Therapy for Vancomycin-Resistant Enterococcus faecium Infections: Review of the Current Evidence.
    Pharmacotherapy, 2017, Volume: 37, Issue:5

    Topics: Animals; Anti-Bacterial Agents; Cross Infection; Drug Therapy, Combination; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Teicoplanin; Vancomycin; Vancomycin Resistance; Virginiamycin

2017

Trials

5 trial(s) available for vancomycin and virginiamycin

ArticleYear
Treatment of vancomycin-resistant Enterococcus faecium infections with an investigational streptogramin antibiotic (quinupristin/dalfopristin): a report of fifteen cases.
    Microbial drug resistance (Larchmont, N.Y.), 1996,Winter, Volume: 2, Issue:4

    Topics: Adult; Aged; Anti-Bacterial Agents; DNA, Bacterial; Drug Resistance, Microbial; Electrophoresis, Polyacrylamide Gel; Enterococcus faecium; Female; Gram-Negative Bacterial Infections; Humans; Injections, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Vancomycin; Virginiamycin

1996
Effect of quinupristin/dalfopristin on the outcome of vancomycin-resistant Enterococcus faecium bacteraemia: comparison with a control cohort.
    The Journal of antimicrobial chemotherapy, 1997, Volume: 39 Suppl A

    Topics: Adult; Anti-Bacterial Agents; Bacteremia; Cohort Studies; Drug Resistance, Microbial; Enterococcus faecium; Female; Follow-Up Studies; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Treatment Outcome; Vancomycin; Virginiamycin

1997
Prospective, randomized dose-ranging open phase II pilot study of quinupristin/dalfopristin versus vancomycin in the treatment of catheter-related staphylococcal bacteremia.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1999, Volume: 18, Issue:3

    Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Catheterization; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pilot Projects; Prospective Studies; Single-Blind Method; Staphylococcal Infections; Vancomycin; Virginiamycin

1999
Treatment of hospitalized patients with complicated gram-positive skin and skin structure infections: two randomized, multicentre studies of quinupristin/dalfopristin versus cefazolin, oxacillin or vancomycin. Synercid Skin and Skin Structure Infection Gr
    The Journal of antimicrobial chemotherapy, 1999, Volume: 44, Issue:2

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Cefazolin; Cephalosporins; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Hospitalization; Humans; Male; Middle Aged; Oxacillin; Penicillins; Skin Diseases, Bacterial; Vancomycin; Virginiamycin

1999
Treatment of gram-positive nosocomial pneumonia. Prospective randomized comparison of quinupristin/dalfopristin versus vancomycin. Nosocomial Pneumonia Group.
    American journal of respiratory and critical care medicine, 2000, Volume: 161, Issue:3 Pt 1

    Topics: Adult; Aged; Anti-Bacterial Agents; Cross Infection; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pneumonia, Pneumococcal; Pneumonia, Staphylococcal; Prospective Studies; Treatment Outcome; Vancomycin; Virginiamycin

2000

Other Studies

118 other study(ies) available for vancomycin and virginiamycin

ArticleYear
Susceptibilities of penicillin-susceptible and -resistant strains of Streptococcus pneumoniae to RP 59500, vancomycin, erythromycin, PD 131628, sparfloxacin, temafloxacin, win 57273, ofloxacin, and ciprofloxacin.
    Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:4

    Topics: Anti-Infective Agents; Ciprofloxacin; Erythromycin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Penicillin Resistance; Quinolones; Streptococcus pneumoniae; Vancomycin; Virginiamycin

1992
Pristinamycin for Enterococcus faecium resistant to vancomycin and gentamicin.
    Lancet (London, England), 1992, Feb-01, Volume: 339, Issue:8788

    Topics: Child; Drug Resistance, Microbial; Enterococcus faecium; Gentamicins; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Vancomycin; Virginiamycin

1992
Studies of RP 59500 in vitro and in a rabbit model of aortic valve endocarditis caused by methicillin-resistant Staphylococcus aureus.
    The Journal of antimicrobial chemotherapy, 1992, Volume: 30 Suppl A

    Topics: Animals; Aortic Valve; Drug Combinations; Drug Resistance, Microbial; Endocarditis, Bacterial; Heart Valve Diseases; In Vitro Techniques; Methicillin; Microbial Sensitivity Tests; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Virginiamycin

1992
The in-vitro activity of RP 59500 against gram-positive cocci.
    The Journal of antimicrobial chemotherapy, 1992, Volume: 30 Suppl A

    Topics: Amoxicillin; Ciprofloxacin; Erythromycin; Gram-Positive Cocci; In Vitro Techniques; Josamycin; Methicillin Resistance; Microbial Sensitivity Tests; Vancomycin; Virginiamycin

1992
Comparative in-vitro activity of RP 59500.
    The Journal of antimicrobial chemotherapy, 1992, Volume: 30 Suppl A

    Topics: Bacteria; Ciprofloxacin; Clindamycin; Drug Resistance, Microbial; Erythromycin; Gentamicins; In Vitro Techniques; Microbial Sensitivity Tests; Oxacillin; Vancomycin; Virginiamycin

1992
Comparative efficacy of pefloxacin and six other antimicrobial agents on Staphylococcus aureus experimental abscesses.
    The Journal of antimicrobial chemotherapy, 1986, Volume: 17 Suppl B

    Topics: Abscess; Administration, Oral; Animals; Anti-Bacterial Agents; Cephalothin; Ciprofloxacin; Injections, Subcutaneous; Methicillin; Mice; Norfloxacin; Pefloxacin; Penicillin Resistance; Peptides; Quinolines; Staphylococcal Infections; Staphylococcus aureus; Thigh; Vancomycin; Virginiamycin

1986
In-vitro susceptibility of oral streptococci to pristinamycin.
    The Journal of antimicrobial chemotherapy, 1987, Volume: 19, Issue:5

    Topics: Amoxicillin; Anti-Bacterial Agents; Erythromycin; Humans; Microbial Sensitivity Tests; Mouth; Peptides; Streptococcus; Vancomycin; Virginiamycin

1987
[Corynebacterium group D2. Clinical study, biochemical identification and antibiotic sensitivity].
    Pathologie-biologie, 1988, Volume: 36, Issue:5

    Topics: Anti-Bacterial Agents; Ciprofloxacin; Corynebacterium; Corynebacterium Infections; Drug Resistance, Microbial; Enoxacin; Female; Humans; Male; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Peptides, Cyclic; Pipemidic Acid; Rifampin; Tetracycline; Tetracycline Resistance; Urinary Tract Infections; Vancomycin; Virginiamycin

1988
Comparative in-vitro activity of erythromycin, vancomycin and pristinamycin.
    Infection, 1988, Volume: 16, Issue:6

    Topics: Bacteria; Enterobacteriaceae; Erythromycin; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Staphylococcus aureus; Streptococcus; Vancomycin; Virginiamycin

1988
[New antibiotics, with the exception of penicillins, streptomycin, tetracyclines and chloramphenicol].
    Antibiotica et chemotherapia. Fortschritte. Advances. Progres, 1968, Volume: 14

    Topics: Anti-Bacterial Agents; Cephalosporins; Chemistry, Pharmaceutical; Erythromycin; Fusidic Acid; Gentamicins; Kanamycin; Leucomycins; Lincomycin; Neomycin; Novobiocin; Oleandomycin; Paromomycin; Polymyxins; Rifampin; Ristocetin; Spectinomycin; Vancomycin; Virginiamycin

1968
[Sensitivity of staphylococci to antibiotics].
    Chemotherapy, 1966, Volume: 11, Issue:6

    Topics: Ampicillin; Anti-Bacterial Agents; Cephalothin; Chloramphenicol; Chlortetracycline; Culture Media; Erythromycin; Kanamycin; Methicillin; Oxytetracycline; Penicillin G; Penicillin Resistance; Rifampin; Staphylococcus; Streptomycin; Vancomycin; Virginiamycin

1966
[In vitro study of strains of Staphylococcus: choice of an antibiotic].
    La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris, 1984, May-03, Volume: 60, Issue:19

    Topics: Anti-Bacterial Agents; Cephalothin; Drug Resistance, Microbial; Fosfomycin; Microbial Sensitivity Tests; Staphylococcus; Staphylococcus aureus; Vancomycin; Virginiamycin

1984
Treatment of experimental endocarditis due to erythromycin-susceptible or -resistant methicillin-resistant Staphylococcus aureus with RP 59500.
    Antimicrobial agents and chemotherapy, 1995, Volume: 39, Issue:7

    Topics: Animals; Drug Resistance, Microbial; Endocarditis, Bacterial; Erythromycin; Female; Methicillin Resistance; Microbial Sensitivity Tests; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Virginiamycin

1995
RP 59500 prophylaxis of experimental endocarditis due to erythromycin-susceptible and -resistant isogenic pairs of viridans group streptococci.
    Antimicrobial agents and chemotherapy, 1995, Volume: 39, Issue:7

    Topics: Animals; Conjugation, Genetic; Drug Resistance, Microbial; Endocarditis, Bacterial; Erythromycin; Female; Microbial Sensitivity Tests; Rats; Rats, Wistar; Streptococcal Infections; Streptococcus; Vancomycin; Virginiamycin

1995
Pharmacodynamics of RP 59500 alone and in combination with vancomycin against Staphylococcus aureus in an in vitro-infected fibrin clot model.
    Antimicrobial agents and chemotherapy, 1995, Volume: 39, Issue:7

    Topics: Blood Coagulation; Drug Therapy, Combination; Fibrin; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Thrombosis; Vancomycin; Virginiamycin

1995
Critical influence of resistance to streptogramin B-type antibiotics on activity of RP 59500 (quinupristin-dalfopristin) in experimental endocarditis due to Staphylococcus aureus.
    Antimicrobial agents and chemotherapy, 1995, Volume: 39, Issue:2

    Topics: Animals; Drug Resistance, Microbial; Endocarditis, Bacterial; Female; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Virginiamycin

1995
In vitro antimicrobial susceptibility of glycopeptide-resistant enterococci.
    Diagnostic microbiology and infectious disease, 1995, Volume: 21, Issue:1

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Depsipeptides; Drug Resistance, Microbial; Enterococcus; Fluoroquinolones; Fusidic Acid; Microbial Sensitivity Tests; Minocycline; Naphthyridines; Novobiocin; Peptides, Cyclic; Quinolones; Teicoplanin; Vancomycin; Virginiamycin

1995
Study of comparative antipneumococcal activities of penicillin G, RP 59500, erythromycin, sparfloxacin, ciprofloxacin, and vancomycin by using time-kill methodology.
    Antimicrobial agents and chemotherapy, 1994, Volume: 38, Issue:9

    Topics: Anti-Infective Agents; Ciprofloxacin; Erythromycin; Fluoroquinolones; Kinetics; Microbial Sensitivity Tests; Penicillin G; Quinolones; Streptococcus pneumoniae; Time Factors; Vancomycin; Virginiamycin

1994
In vivo activities and penetration of the two components of the streptogramin RP 59500 in cardiac vegetations of experimental endocarditis.
    Antimicrobial agents and chemotherapy, 1994, Volume: 38, Issue:3

    Topics: Animals; Autoradiography; Culture Media; Drug Synergism; Endocarditis, Bacterial; Female; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus sanguis; Vancomycin; Virginiamycin

1994
In vitro activity of RP59500, an injectable streptogramin antibiotic, against vancomycin-resistant gram-positive organisms.
    Antimicrobial agents and chemotherapy, 1993, Volume: 37, Issue:3

    Topics: Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Vancomycin; Virginiamycin

1993
Bactericidal activity and kinetics of RP 59500 in a mouse model of Staphylococcus aureus septicaemia.
    The Journal of antimicrobial chemotherapy, 1995, Volume: 36, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Bacteremia; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Serum Bactericidal Test; Software; Staphylococcal Infections; Vancomycin; Virginiamycin

1995
Selection of Enterococcus faecium strains with stable and unstable resistance to the streptogramin RP 59500 using stepwise in vitro exposure.
    Diagnostic microbiology and infectious disease, 1996, Volume: 25, Issue:1

    Topics: Anti-Bacterial Agents; Culture Media; Drug Resistance, Microbial; Enterococcus faecium; Microbial Sensitivity Tests; Vancomycin; Virginiamycin

1996
Intracellular activities of RP 59500 (quinupristin-dalfopristin) and sparfloxacin against Enterococcus faecium.
    Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:4

    Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Drug Resistance, Microbial; Enterococcus faecium; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Neutrophils; Quinolones; Vancomycin; Virginiamycin

1996
In vitro activity of LY333328, an investigational glycopeptide antibiotic, against enterococci and staphylococci.
    Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:10

    Topics: Anti-Bacterial Agents; Enterococcus; Glycopeptides; Lipoglycopeptides; Microbial Sensitivity Tests; Staphylococcus; Teicoplanin; Vancomycin; Virginiamycin

1996
Activity of the quinupristin-dalfopristin combination (RP-59500; Synercid) tested against vancomycin-resistant Enterococcus species.
    Diagnostic microbiology and infectious disease, 1996, Volume: 24, Issue:1

    Topics: Anti-Bacterial Agents; Drug Combinations; Drug Resistance, Microbial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Vancomycin; Virginiamycin

1996
Emergence of increased resistance to quinupristin/dalfopristin during therapy for Enterococcus faecium bacteremia.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1997, Volume: 24, Issue:1

    Topics: Adult; Anti-Bacterial Agents; Bacteremia; Drug Resistance, Microbial; Drug Resistance, Multiple; Echocardiography; Enterococcus faecium; Gram-Positive Bacterial Infections; HIV Infections; Humans; Male; Microbial Sensitivity Tests; Vancomycin; Virginiamycin

1997
Superinfection with Enterococcus faecalis during quinupristin/dalfopristin therapy.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1997, Volume: 24, Issue:1

    Topics: Adult; Aged; Ampicillin; Anti-Bacterial Agents; Coronary Artery Bypass; Diabetes Mellitus, Type 1; Drug Hypersensitivity; Endocarditis; Enterococcus faecalis; Gentamicins; Gram-Positive Bacterial Infections; Humans; Male; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Penicillins; Renal Dialysis; Staphylococcal Infections; Staphylococcus aureus; Superinfection; Vancomycin; Virginiamycin; Wound Infection

1997
In vitro study of the potential role of quinupristin/dalfopristin in the treatment of catheter-related staphylococcal infections.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1996, Volume: 15, Issue:12

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Bacteremia; Catheterization, Central Venous; Cefamandole; Cephalosporins; Ciprofloxacin; Clindamycin; Daptomycin; Humans; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Neoplasms; Novobiocin; Oxacillin; Penicillins; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Teicoplanin; Vancomycin; Virginiamycin

1996
Comparative in-vitro activities of RP59500 (quinupristin/dalfopristin), CL 329,998, CL 331,002, trovafloxacin, clinafloxacin, teicoplanin and vancomycin against Gram-positive bacteria.
    The Journal of antimicrobial chemotherapy, 1997, Volume: 39, Issue:3

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Fluoroquinolones; Gram-Positive Bacteria; Microbial Sensitivity Tests; Minocycline; Naphthyridines; Quinolones; Teicoplanin; Tetracyclines; Vancomycin; Virginiamycin

1997
Quinupristin/dalfopristin (RP 59500) therapy for vancomycin-resistant Enterococcus faecium aortic graft infection: case report.
    Microbial drug resistance (Larchmont, N.Y.), 1995,Fall, Volume: 1, Issue:3

    Topics: Anti-Bacterial Agents; Arteries; Coronary Artery Bypass; Drug Resistance, Microbial; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Middle Aged; Postoperative Complications; Vancomycin; Virginiamycin

1995
In vitro activity of RP 59500 (quinupristin/dalfopristin) and ramoplanin against vancomycin-resistant Enterococcus faecium.
    Microbial drug resistance (Larchmont, N.Y.), 1995,Winter, Volume: 1, Issue:4

    Topics: Anti-Bacterial Agents; Colony Count, Microbial; Depsipeptides; Drug Resistance, Microbial; Enterococcus faecium; Genes, Bacterial; Gram-Positive Bacterial Infections; Humans; Kinetics; Microbial Sensitivity Tests; Peptides, Cyclic; Phenotype; Vancomycin; Virginiamycin

1995
Persistence of vancomycin-resistant Enterococcus faecium gastrointestinal tract colonization in antibiotic-treated mice.
    Microbial drug resistance (Larchmont, N.Y.), 1996,Winter, Volume: 2, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Biliary Tract; Colony Count, Microbial; Digestive System; Drug Resistance, Microbial; Enterococcus faecium; Feces; Female; Liver; Mice; Vancomycin; Virginiamycin

1996
In vitro susceptibilities of clinical isolates of vancomycin-resistant enterococci.
    Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:6

    Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Chloramphenicol; Ciprofloxacin; Doxycycline; Drug Resistance, Microbial; Enterococcus faecalis; Enterococcus faecium; Microbial Sensitivity Tests; Penicillins; Vancomycin; Virginiamycin

1997
Therapy with RP 59500 (quinupristin/dalfopristin) for prosthetic valve endocarditis due to enterococci with VanA/VanB resistance patterns.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1997, Volume: 25, Issue:1

    Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Endocarditis, Bacterial; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Middle Aged; Prosthesis-Related Infections; Vancomycin; Virginiamycin

1997
Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci.
    Lancet (London, England), 1997, Sep-06, Volume: 350, Issue:9079

    Topics: Animals; Anti-Bacterial Agents; Chickens; Drug Resistance, Microbial; Enterococcus; Humans; Microbial Sensitivity Tests; Vancomycin; Virginiamycin

1997
Vancomycin-resistant enterococci osteomyelitis in the foot. A case report.
    Journal of the American Podiatric Medical Association, 1997, Volume: 87, Issue:9

    Topics: Aged; Anti-Bacterial Agents; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterococcus; Humans; Male; Osteomyelitis; Tarsal Bones; Vancomycin; Virginiamycin

1997
High prevalence of colonization with vancomycin- and pristinamycin-resistant enterococci in healthy humans and pigs in The Netherlands: is the addition of antibiotics to animal feeds to blame?
    The Journal of antimicrobial chemotherapy, 1997, Volume: 40, Issue:3

    Topics: Animal Feed; Animals; Drug Resistance, Microbial; Enterococcus; Feces; Humans; Microbial Sensitivity Tests; Netherlands; Vancomycin; Virginiamycin

1997
In vitro activity of chloramphenicol alone and in combination with vancomycin, ampicillin, or RP 59500 (quinupristin/dalfopristin) against vancomycin-resistant enterococci.
    Diagnostic microbiology and infectious disease, 1997, Volume: 29, Issue:3

    Topics: Ampicillin; Anti-Bacterial Agents; Chloramphenicol; Cross Infection; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Penicillins; Vancomycin; Virginiamycin

1997
Influence of erythromycin resistance, inoculum growth phase, and incubation time on assessment of the bactericidal activity of RP 59500 (quinupristin-dalfopristin) against vancomycin-resistant Enterococcus faecium.
    Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:12

    Topics: Anti-Bacterial Agents; Cell Cycle; Drug Resistance, Microbial; Enterococcus faecium; Erythromycin; Microbial Sensitivity Tests; Time Factors; Vancomycin; Virginiamycin

1997
Antimicrobial susceptibility of viridans group streptococci.
    Diagnostic microbiology and infectious disease, 1997, Volume: 29, Issue:4

    Topics: Amoxicillin; Anti-Bacterial Agents; Cefazolin; Ceftriaxone; Clindamycin; Drug Resistance, Microbial; Gentamicins; Humans; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Rifampin; Streptococcal Infections; Streptococcus; Thienamycins; Vancomycin; Virginiamycin

1997
Bactericidal and inhibitory activity of quinupristin/dalfopristin against vancomycin- and gentamicin-resistant Enterococcus faecium.
    The Journal of antimicrobial chemotherapy, 1997, Volume: 39 Suppl A

    Topics: Anti-Bacterial Agents; Colony Count, Microbial; Drug Resistance, Multiple; Enterococcus faecium; Gentamicins; Humans; Microbial Sensitivity Tests; Vancomycin; Virginiamycin

1997
In-vitro bactericidal activity of quinupristin/dalfopristin alone and in combination against resistant strains of Enterococcus species and Staphylococcus aureus.
    The Journal of antimicrobial chemotherapy, 1997, Volume: 39 Suppl A

    Topics: Anti-Bacterial Agents; Colony Count, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Enterococcus; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus; Time Factors; Vancomycin; Virginiamycin

1997
Comparative in-vitro activity of quinupristin/dalfopristin against Enterococcus spp.
    The Journal of antimicrobial chemotherapy, 1997, Volume: 39 Suppl A

    Topics: Amoxicillin; Anti-Bacterial Agents; Enterococcus; Erythromycin; Humans; Microbial Sensitivity Tests; Teicoplanin; Vancomycin; Virginiamycin

1997
Synergic activity of vancomycin-quinupristin/dalfopristin combination against Enterococcus faecium.
    The Journal of antimicrobial chemotherapy, 1997, Volume: 39 Suppl A

    Topics: Colony Count, Microbial; Drug Synergism; Drug Therapy, Combination; Enterococcus faecium; Humans; Microbial Sensitivity Tests; Vancomycin; Virginiamycin

1997
Antistaphylococcal activities of quinupristin/dalfopristin in vitro across platelet-fibrin matrices and in experimental endocarditis.
    The Journal of antimicrobial chemotherapy, 1997, Volume: 39 Suppl A

    Topics: Animals; Anti-Bacterial Agents; Blood Platelets; Colony Count, Microbial; Endocarditis, Bacterial; Male; Methicillin Resistance; Microbial Sensitivity Tests; Rabbits; Staphylococcus aureus; Vancomycin; Virginiamycin

1997
Stability of the MICs of various antibiotics in different clonal populations of methicillin-resistant Staphylococcus aureus.
    The Journal of antimicrobial chemotherapy, 1998, Volume: 41, Issue:2

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Fluoroquinolones; Germany; Hospitals; Humans; Longitudinal Studies; Methicillin Resistance; Microbial Sensitivity Tests; Minocycline; Staphylococcus aureus; Teicoplanin; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin; Virginiamycin

1998
Characterization of vancomycin-resistant Enterococcus faecium isolates from the United States and their susceptibility in vitro to dalfopristin-quinupristin.
    Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:5

    Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Enterococcus faecium; Humans; Microbial Sensitivity Tests; United States; Vancomycin; Virginiamycin

1998
Staphylococcus epidermidis endocarditis treated with RP 59500 (quinapristin/dalfopristin).
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1998, Volume: 26, Issue:5

    Topics: Adult; Anti-Bacterial Agents; Endocarditis, Bacterial; Humans; Male; Methicillin Resistance; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin; Virginiamycin

1998
Intraventricular quinupristin/dalfopristin for the treatment of vancomycin-resistant Enterococcus faecium shunt infection.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1998, Volume: 26, Issue:6

    Topics: Adult; Anti-Bacterial Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Injections, Intraventricular; Male; Vancomycin; Ventriculoperitoneal Shunt; Virginiamycin

1998
Effect of quinupristin/dalfopristin alone or in combination with vancomycin on the structure of Enterococcus faecium.
    Drugs under experimental and clinical research, 1998, Volume: 24, Issue:2

    Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus faecium; Microbial Sensitivity Tests; Microscopy, Electron; Vancomycin; Virginiamycin

1998
Pharmacodynamic analysis of the activity of quinupristin-dalfopristin against vancomycin-resistant Enterococcus faecium with differing MBCs via time-kill-curve and postantibiotic effect methods.
    Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:9

    Topics: Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus faecium; Microbial Sensitivity Tests; Vancomycin; Virginiamycin

1998
Treatment of vancomycin-resistant Enterococcus faecium with RP 59500 (quinupristin-dalfopristin) administered by intermittent or continuous infusion, alone or in combination with doxycycline, in an in vitro pharmacodynamic infection model with simulated e
    Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:10

    Topics: Anti-Bacterial Agents; Doxycycline; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus faecium; Humans; Microbial Sensitivity Tests; Vancomycin; Virginiamycin

1998
Association between quinupristin/dalfopristin resistance in glycopeptide-resistant Enterococcus faecium and the use of additives in animal feed.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1998, Volume: 17, Issue:6

    Topics: Animal Feed; Animals; Anti-Bacterial Agents; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterococcus faecium; Food Additives; Meat; Meat Products; Vancomycin; Virginiamycin

1998
Postantibiotic effect and postantibiotic sub-MIC effect of quinupristin-dalfopristin against gram-positive and -negative organisms.
    Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:11

    Topics: Anti-Bacterial Agents; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Vancomycin; Virginiamycin

1998
In vitro activity of RPR 106972 alone and in combination with vancomycin, ampicillin, and gentamicin against multidrug-resistant enterococci.
    Diagnostic microbiology and infectious disease, 1998, Volume: 32, Issue:2

    Topics: Ampicillin; Anti-Bacterial Agents; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Synergism; Drug Therapy, Combination; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Gentamicins; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Vancomycin; Virginiamycin

1998
Treatment of endocarditis due to vancomycin-resistant Enterococcus faecium with quinupristin/dalfopristin, doxycycline, and rifampin: a synergistic drug combination.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1998, Volume: 27, Issue:6

    Topics: Aged; Doxycycline; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Male; Rifampin; Vancomycin; Virginiamycin

1998
Comparative activities of clinafloxacin, grepafloxacin, levofloxacin, moxifloxacin, ofloxacin, sparfloxacin, and trovafloxacin and nonquinolones linozelid, quinupristin-dalfopristin, gentamicin, and vancomycin against clinical isolates of ciprofloxacin-re
    Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:2

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Gentamicins; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Ofloxacin; Piperazines; Quinolines; Quinolones; Staphylococcus aureus; Vancomycin; Virginiamycin

1999
Activity of clinafloxacin, trovafloxacin, quinupristin/dalfopristin, and other antimicrobial agents versus Staphylococcus aureus isolates with reduced susceptibility to vancomycin.
    Diagnostic microbiology and infectious disease, 1999, Volume: 33, Issue:1

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines; Staphylococcus aureus; Vancomycin; Virginiamycin

1999
Evaluation of bactericidal activities of LY333328, vancomycin, teicoplanin, ampicillin-sulbactam, trovafloxacin, and RP59500 alone or in combination with rifampin or gentamicin against different strains of vancomycin-intermediate Staphylococcus aureus by
    Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:3

    Topics: Ampicillin; Anti-Bacterial Agents; Antibiotics, Antitubercular; Drug Therapy, Combination; Fluoroquinolones; Gentamicins; Glycopeptides; Lipoglycopeptides; Microbial Sensitivity Tests; Naphthyridines; Rifampin; Staphylococcus aureus; Sulbactam; Teicoplanin; Time Factors; Vancomycin; Virginiamycin

1999
Antimicrobial resistance in gram-positive pathogens isolated in the UK between October 1996 and January 1997.
    The Journal of antimicrobial chemotherapy, 1999, Volume: 43, Issue:5

    Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Enterococcus faecium; Environmental Monitoring; Gram-Positive Bacteria; Hospitals; Humans; Microbial Sensitivity Tests; Staphylococcus; Streptococcus pneumoniae; United Kingdom; Vancomycin; Virginiamycin

1999
[Susceptibilities of Enterococcus faecium, PRSP and MRSA to RP59500 and their correlations with those to other drugs].
    The Japanese journal of antibiotics, 1999, Volume: 52, Issue:4

    Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Enterococcus faecium; Humans; Methicillin Resistance; Penicillin Resistance; Staphylococcus aureus; Streptococcus pneumoniae; Vancomycin; Virginiamycin

1999
Plasmid-mediated coresistance to streptogramins and vancomycin in Enterococcus faecium HM1032.
    Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:8

    Topics: Anti-Bacterial Agents; Drug Resistance, Multiple; Enterococcus faecium; Humans; Plasmids; Vancomycin; Virginiamycin

1999
Synergy testing of vancomycin-resistant Enterococcus faecium against quinupristin-dalfopristin in combination with other antimicrobial agents.
    Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:11

    Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Drug Synergism; Enterococcus faecium; Genotype; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Time Factors; Vancomycin; Vancomycin Resistance; Virginiamycin

1999
Modified time-kill assay against multidrug-resistant Enterococcus faecium with novel antimicrobial combinations.
    The Journal of antimicrobial chemotherapy, 1999, Volume: 44, Issue:6

    Topics: Ampicillin; Chloramphenicol; Colony Count, Microbial; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Enterococcus faecium; Gentamicins; Kinetics; Microbial Sensitivity Tests; Time Factors; Vancomycin; Virginiamycin

1999
In vitro activities of daptomycin, vancomycin, linezolid, and quinupristin-dalfopristin against Staphylococci and Enterococci, including vancomycin- intermediate and -resistant strains.
    Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:4

    Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Multiple; Enterococcus; Linezolid; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Staphylococcus; Time Factors; Vancomycin; Virginiamycin

2000
Bactericidal activity of quinupristin-dalfopristin against Staphylococcus aureus: clindamycin susceptibility as a surrogate indicator.
    Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:10

    Topics: Anti-Bacterial Agents; Clindamycin; Drug Resistance, Microbial; Drug Therapy, Combination; Microbial Sensitivity Tests; Phenotype; Staphylococcus aureus; Time Factors; Vancomycin; Virginiamycin

2000
Treatment of a vancomycin-resistant Enterococcus faecium ventricular drain infection with quinupristin/dalfopristin and review of the literature.
    The Journal of infection, 2000, Volume: 41, Issue:1

    Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Enterococcus faecium; Fatal Outcome; Female; Gram-Positive Bacterial Infections; Humans; Hydrocephalus; Injections, Intravenous; Injections, Intraventricular; Injections, Spinal; Linezolid; Middle Aged; Oxazoles; Oxazolidinones; Subarachnoid Hemorrhage; Tomography, X-Ray Computed; Vancomycin; Ventriculoperitoneal Shunt; Virginiamycin

2000
Streptogramin resistance and shared pulsed-field gel electrophoresis patterns in vanA-containing Enterococcus faecium and Enterococcus hirae isolated from humans and animals in Spain.
    Microbial drug resistance (Larchmont, N.Y.), 2000,Winter, Volume: 6, Issue:4

    Topics: Acetyltransferases; Animals; Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Chickens; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Enterococcus; Enterococcus faecium; Feces; Humans; Microbial Sensitivity Tests; Spain; Vancomycin; Virginiamycin

2000
Antibiotic resistance rates and macrolide resistance phenotypes of viridans group streptococci from the oropharynx of healthy Greek children.
    International journal of antimicrobial agents, 2001, Volume: 17, Issue:3

    Topics: Adolescent; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Child; Child, Preschool; Clarithromycin; Clindamycin; Drug Resistance, Microbial; Erythromycin; Female; Fluoroquinolones; Greece; Humans; Infant; Male; Microbial Sensitivity Tests; Oropharynx; Phenotype; Rifampin; Streptococcus; Tetracycline; Vancomycin; Virginiamycin

2001
In vitro activity of 19 antimicrobial agents against enterococci from healthy subjects and hospitalized patients and use of an ace gene probe from Enterococcus faecalis for species identification.
    Microbial drug resistance (Larchmont, N.Y.), 2001,Spring, Volume: 7, Issue:1

    Topics: Adhesins, Bacterial; Anti-Bacterial Agents; DNA, Bacterial; Drug Resistance, Microbial; Enterococcus faecalis; Feces; Genes, Bacterial; Gentamicins; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Molecular Probes; Species Specificity; Vancomycin; Virginiamycin

2001
Comparative study of treatment with penicillin, ceftriaxone, trovafloxacin, quinupristin-dalfopristin and vancomycin in experimental endocarditis due to penicillin- and ceftriaxone-resistant Streptococcus pneumoniae.
    The Journal of antimicrobial chemotherapy, 2001, Volume: 47, Issue:5

    Topics: Animals; Anti-Infective Agents; Ceftriaxone; Disease Models, Animal; Drug Resistance, Multiple; Endocarditis, Bacterial; Fluoroquinolones; Humans; Male; Naphthyridines; Penicillin Resistance; Penicillins; Pneumococcal Infections; Rabbits; Streptococcus pneumoniae; Vancomycin; Virginiamycin

2001
Implications of multiple antimicrobial-resistant enterococci associated with the poultry environment.
    Food additives and contaminants, 2001, Volume: 18, Issue:12

    Topics: Animals; Drug Resistance, Multiple, Bacterial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Feces; Food Microbiology; Gentamicins; Penicillins; Poultry; Streptomycin; United States; Vancomycin; Virginiamycin

2001
Antibiotic resistance. Livestock feed ban preserves drugs' power.
    Science (New York, N.Y.), 2002, Jan-04, Volume: 295, Issue:5552

    Topics: Animal Feed; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Chickens; Drug Resistance, Bacterial; Enrofloxacin; Enterococcus; Europe; Feces; Fluoroquinolones; Glycopeptides; Humans; Quinolones; Swine; United States; United States Food and Drug Administration; Vancomycin; Vancomycin Resistance; Virginiamycin

2002
In vitro bactericidal activity of daptomycin against staphylococci.
    The Journal of antimicrobial chemotherapy, 2002, Volume: 49, Issue:3

    Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Therapy, Combination; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Staphylococcus; Vancomycin; Virginiamycin

2002
Combination of quinupristin-dalfopristin (Synercid) and rifampin is highly synergistic in experimental Staphylococcus aureus joint prosthesis infection.
    Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Antibiotics, Antitubercular; Drug Synergism; Drug Therapy, Combination; Joint Prosthesis; Methicillin Resistance; Prosthesis-Related Infections; Rabbits; Rifampin; Staphylococcal Infections; Tissue Distribution; Vancomycin; Virginiamycin

2002
Synercid plus vancomycin for the treatment of severe methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci infections: evaluation of 5 cases.
    Scandinavian journal of infectious diseases, 2002, Volume: 34, Issue:2

    Topics: Abdominal Abscess; Adult; Aged; Anti-Bacterial Agents; Coagulase; Drug Therapy, Combination; Endocarditis; Female; Heart-Assist Devices; Humans; Male; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Virginiamycin

2002
Combination of quinupristin/dalfopristin and glycopeptide in severe methicillin-resistant staphylococcal infections failing previous glycopeptide regimens.
    Infection, 2002, Volume: 30, Issue:3

    Topics: Adult; Aged; Anti-Bacterial Agents; Colony Count, Microbial; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Methicillin Resistance; Microbial Sensitivity Tests; Sampling Studies; Sensitivity and Specificity; Severity of Illness Index; Staphylococcal Infections; Teicoplanin; Treatment Outcome; Vancomycin; Virginiamycin

2002
In vitro activity of linezolid, synercid and telithromycin against genetically defined high level fluoroquinolone-resistant methicillin-resistant Staphylococcus aureus.
    International journal of antimicrobial agents, 2002, Volume: 20, Issue:1

    Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Bacterial; Drug Resistance, Multiple; In Vitro Techniques; Ketolides; Linezolid; Macrolides; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcus aureus; Vancomycin; Virginiamycin

2002
In vitro activity of linezolid, quinupristin-dalfopristin, vancomycin, teicoplanin, moxifloxacin and mupirocin against methicillin-resistant Staphylococcus aureus: comparative evaluation by the E test and a broth microdilution method.
    Diagnostic microbiology and infectious disease, 2002, Volume: 43, Issue:4

    Topics: Acetamides; Anti-Bacterial Agents; Aza Compounds; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Moxifloxacin; Mupirocin; Oxazolidinones; Quinolines; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin; Virginiamycin

2002
Efficacies of quinupristin-dalfopristin combined with vancomycin in vitro and in experimental endocarditis due to methicillin-resistant Staphylococcus aureus in relation to cross-resistance to macrolides, lincosamides, and streptogramin B- type antibiotic
    Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:9

    Topics: Animals; Anti-Bacterial Agents; Culture Media; Drug Resistance; Drug Therapy, Combination; Endocarditis, Bacterial; Lincosamides; Macrolides; Methicillin Resistance; Microbial Sensitivity Tests; Rabbits; Staphylococcus aureus; Streptogramin B; Time Factors; Vancomycin; Virginiamycin

2002
Disseminated oxacillin-resistant Staphylococcus aureus infection responsive to vancomycin and quinupristin-dalfopristin combination therapy.
    The Journal of antimicrobial chemotherapy, 2003, Volume: 51, Issue:1

    Topics: Aged; Drug Therapy, Combination; Female; Humans; Oxacillin; Penicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Virginiamycin

2003
In vitro activities of daptomycin, vancomycin, quinupristin- dalfopristin, linezolid, and five other antimicrobials against 307 gram-positive anaerobic and 31 Corynebacterium clinical isolates.
    Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:1

    Topics: Acetamides; Anti-Bacterial Agents; Corynebacterium; Daptomycin; Gram-Positive Bacteria; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Vancomycin; Virginiamycin

2003
Comparative in vitro activity of quinupristin/dalfopristin and seven other antimicrobials against methicillin-susceptible and methicillin-resistant nosocomial Staphylococcus aureus bloodstream isolates.
    Journal of chemotherapy (Florence, Italy), 2002, Volume: 14, Issue:6

    Topics: Anti-Bacterial Agents; Bacteremia; Clindamycin; Cross Infection; Erythromycin; Gentamicins; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Oxacillin; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin; Virginiamycin

2002
Treatment of central nervous system infection by vancomycin-resistant enterococcus faecium.
    Diagnostic microbiology and infectious disease, 2003, Volume: 45, Issue:3

    Topics: Aged; Brain Neoplasms; Central Nervous System Infections; Drug Resistance, Bacterial; Drug Therapy, Combination; Enterococcus faecium; Follow-Up Studies; Gram-Positive Bacterial Infections; Humans; Injections, Intralesional; Lymphoma; Male; Opportunistic Infections; Risk Assessment; Treatment Outcome; Vancomycin; Virginiamycin

2003
Relations between the consumption of antimicrobial growth promoters and the occurrence of resistance among Enterococcus faecium isolated from broilers.
    Epidemiology and infection, 2004, Volume: 132, Issue:1

    Topics: Animal Feed; Animal Husbandry; Animals; Anti-Bacterial Agents; Chickens; Denmark; Drug Administration Schedule; Drug Resistance, Bacterial; Enterococcus faecium; Erythromycin; Gram-Positive Bacterial Infections; Linear Models; Logistic Models; Markov Chains; Microbial Sensitivity Tests; Monte Carlo Method; Oligosaccharides; Poultry Diseases; Time Factors; Vancomycin; Virginiamycin

2004
In vitro post-antibiotic effect of fluoroquinolones, macrolides, beta-lactams, tetracyclines, vancomycin, clindamycin, linezolid, chloramphenicol, quinupristin/dalfopristin and rifampicin on Bacillus anthracis.
    The Journal of antimicrobial chemotherapy, 2004, Volume: 53, Issue:4

    Topics: Acetamides; Anti-Bacterial Agents; Bacillus anthracis; beta-Lactams; Chloramphenicol; Clindamycin; Fluoroquinolones; Linezolid; Macrolides; Microbial Sensitivity Tests; Oxazolidinones; Rifampin; Tetracyclines; Vancomycin; Virginiamycin

2004
Relative susceptibilities to vancomycin and quinupristin-dalfopristin of adhered and planktonic vancomycin-resistant and vancomycin-susceptible coagulase-negative staphylococci.
    Current microbiology, 2004, Volume: 48, Issue:3

    Topics: Anti-Bacterial Agents; Bacterial Adhesion; Biofilms; Catheterization; Coagulase; Drug Resistance, Bacterial; Hydrogels; Methicillin Resistance; Microbial Sensitivity Tests; Silicones; Staphylococcus; Vancomycin; Vancomycin Resistance; Virginiamycin

2004
In vitro activities of cefotaxime, vancomycin, quinupristin/dalfopristin, linezolid and other antibiotics alone and in combination against Propionibacterium acnes isolates from central nervous system infections.
    The Journal of antimicrobial chemotherapy, 2005, Volume: 55, Issue:2

    Topics: Acetamides; Cefotaxime; Central Nervous System Infections; Drug Therapy, Combination; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Propionibacterium acnes; Vancomycin; Virginiamycin

2005
In vitro activity of vancomycin, quinupristin/dalfopristin, and linezolid against intact and disrupted biofilms of staphylococci.
    Annals of clinical microbiology and antimicrobials, 2005, Jan-07, Volume: 4

    Topics: Acetamides; Biofilms; Humans; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcus; Staphylococcus aureus; Staphylococcus epidermidis; Vancomycin; Virginiamycin

2005
Airborne multidrug-resistant bacteria isolated from a concentrated swine feeding operation.
    Environmental health perspectives, 2005, Volume: 113, Issue:2

    Topics: Air Microbiology; Animal Husbandry; Animals; Anti-Bacterial Agents; Clindamycin; Drug Resistance, Bacterial; Enterococcus; Environmental Monitoring; Erythromycin; Inhalation Exposure; Microbial Sensitivity Tests; Mid-Atlantic Region; Staphylococcus; Swine; Tetracycline; Vancomycin; Virginiamycin; Viridans Streptococci

2005
Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus.
    Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:10

    Topics: Acetamides; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Biofilms; Catheters, Indwelling; Ciprofloxacin; Disease Models, Animal; Drug Therapy, Combination; Linezolid; Male; Oxazolidinones; Plankton; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin; Virginiamycin

2005
Synergy of arbekacin-based combinations against vancomycin hetero-intermediate Staphylococcus aureus.
    Journal of Korean medical science, 2006, Volume: 21, Issue:2

    Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Dibekacin; Drug Resistance, Bacterial; Drug Synergism; Humans; In Vitro Techniques; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Sulbactam; Teicoplanin; Vancomycin; Virginiamycin

2006
In vitro activity of antimicrobial agents against oxacillin resistant staphylococci with special reference to Staphylococcus haemolyticus.
    Indian journal of medical microbiology, 2007, Volume: 25, Issue:1

    Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; India; Linezolid; Microbial Sensitivity Tests; Oxacillin; Oxazolidinones; Staphylococcus; Staphylococcus haemolyticus; Teicoplanin; Vancomycin; Virginiamycin

2007
In vitro efficacy and pharmacodynamic indices for antibiotics against coagulase-negative staphylococcus endophthalmitis isolates.
    Ophthalmology, 2007, Volume: 114, Issue:5

    Topics: Acetamides; Administration, Oral; Administration, Topical; Anti-Bacterial Agents; Aqueous Humor; Aza Compounds; Biological Availability; Coagulase; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Microbiological Techniques; Moxifloxacin; Oxazolidinones; Quinolines; Staphylococcal Infections; Staphylococcus; Vancomycin; Virginiamycin

2007
Comparison of the MicroScan system and the agar dilution assay for Quinupristin/Dalfopristin susceptibility of Enterococcus faecium.
    Annals of clinical and laboratory science, 2007,Summer, Volume: 37, Issue:3

    Topics: Anti-Bacterial Agents; Colony Count, Microbial; Drug Resistance, Microbial; Enterococcus faecium; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Reproducibility of Results; Teicoplanin; Vancomycin; Virginiamycin

2007
Efficacy of quinupristin/dalfopristin versus vancomycin, alone or in combination with rifampicin, against methicillin-resistant Staphylococcus aureus in a rabbit arthritis model.
    International journal of antimicrobial agents, 2008, Volume: 31, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Arthritis, Infectious; Disease Models, Animal; Drug Therapy, Combination; Methicillin Resistance; Microbial Sensitivity Tests; Rabbits; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Virginiamycin

2008
A comparative in-vitro evaluation of resistance selection after exposure to teicoplanin, vancomycin, linezolid and quinupristin-dalfopristin in Staphylococcus aureus and Enterococcus spp.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2008, Volume: 14, Issue:6

    Topics: Acetamides; Anti-Bacterial Agents; Colony Count, Microbial; Drug Resistance, Bacterial; Enterococcus faecalis; Enterococcus faecium; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Mutation; Oxazolidinones; Selection, Genetic; Staphylococcus aureus; Teicoplanin; Vancomycin; Virginiamycin

2008
Effect of oxazolidinone, RBx 7644 (ranbezolid), on inhibition of staphylococcal adherence to plastic surfaces.
    Journal of chemotherapy (Florence, Italy), 2008, Volume: 20, Issue:4

    Topics: Acetamides; Anti-Bacterial Agents; Bacterial Adhesion; Biofilms; Dose-Response Relationship, Drug; Furans; Linezolid; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Plastics; Staphylococcus aureus; Staphylococcus epidermidis; Time Factors; Vancomycin; Virginiamycin

2008
[Persistent bacteremia caused by methicillin-resistant Staphylococcus aureus].
    Enfermedades infecciosas y microbiologia clinica, 2008, Volume: 26, Issue:9

    Topics: Aged; Bacteremia; Catheterization, Central Venous; Chronic Disease; Daptomycin; Discitis; Humans; Jugular Veins; Male; Methicillin-Resistant Staphylococcus aureus; Pancreatitis; Rifampin; Staphylococcal Infections; Vancomycin; Virginiamycin

2008
In vitro combinations of five intravenous antibiotics with dalfopristin-quinupristin against Staphylococcus aureus in a 3-dimensional model.
    Journal of chemotherapy (Florence, Italy), 2008, Volume: 20, Issue:6

    Topics: Anti-Bacterial Agents; Drug Therapy, Combination; Fosfomycin; Gentamicins; In Vitro Techniques; Microbial Sensitivity Tests; Minocycline; Rifampin; Staphylococcus aureus; Tigecycline; Vancomycin; Virginiamycin

2008
Characterisation of a Staphylococcus aureus strain with progressive loss of susceptibility to vancomycin and daptomycin during therapy.
    International journal of antimicrobial agents, 2009, Volume: 33, Issue:6

    Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Daptomycin; Drug Resistance, Bacterial; Endocarditis, Bacterial; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin; Virginiamycin

2009
[In vitro activities of quinupristin/dalfopristin in combination with vancomycin and gatifloxacin against Staphylococcus aureus and Enterococcus faecium clinical isolates].
    Mikrobiyoloji bulteni, 2009, Volume: 43, Issue:1

    Topics: Anti-Bacterial Agents; Drug Combinations; Drug Synergism; Enterococcus faecium; Fluoroquinolones; Gatifloxacin; Humans; Staphylococcus aureus; Vancomycin; Virginiamycin

2009
Activity of telavancin against staphylococci and enterococci determined by MIC and resistance selection studies.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:10

    Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; Drug Resistance, Multiple, Bacterial; Enterococcus; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Point Mutation; Staphylococcus; Vancomycin; Virginiamycin

2009
In vitro activity of telavancin against a contemporary worldwide collection of Staphylococcus aureus isolates.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:6

    Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Humans; In Vitro Techniques; Linezolid; Lipoglycopeptides; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Virginiamycin

2010
In vitro activity of the new multivalent glycopeptide-cephalosporin antibiotic TD-1792 against vancomycin-nonsusceptible Staphylococcus isolates.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:9

    Topics: Acetamides; Anti-Bacterial Agents; Cephalosporins; Daptomycin; Glycopeptides; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcus; Staphylococcus aureus; Vancomycin; Vancomycin Resistance; Virginiamycin

2010
Comparison of antimicrobial agents as therapy for experimental endocarditis: caused by methicillin-resistant Staphylococcus aureus.
    Texas Heart Institute journal, 2010, Volume: 37, Issue:4

    Topics: Acetamides; Animals; Anti-Infective Agents; Aortic Valve; Colony Count, Microbial; Disease Models, Animal; Endocarditis, Bacterial; Infusions, Intravenous; Injections, Intravenous; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Rats; Rats, Wistar; Teicoplanin; Time Factors; Vancomycin; Virginiamycin

2010
Isolation and molecular characterization of methicillin-resistant staphylococci from horses, personnel and environmental sites at an equine hospital in Turkey.
    The Journal of veterinary medical science, 2012, Volume: 74, Issue:12

    Topics: Animal Technicians; Animals; Cross Infection; DNA Primers; Electrophoresis, Gel, Pulsed-Field; Genes, MDR; Horse Diseases; Horses; Humans; Methicillin Resistance; Polymerase Chain Reaction; Rifampin; Species Specificity; Staphylococcal Infections; Staphylococcus; Turkey; Vancomycin; Virginiamycin

2012
[Evaluation of antibiotic susceptibilities and VISA-VRSA rates among MRSA strains isolated from hospitalized patients in intensive care units of hospitals in seven provinces of Turkey].
    Mikrobiyoloji bulteni, 2012, Volume: 46, Issue:3

    Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Humans; Intensive Care Units; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Staphylococcal Infections; Teicoplanin; Tigecycline; Turkey; Vancomycin; Vancomycin Resistance; Virginiamycin

2012
Antibiotic pressure can induce the viable but non-culturable state in Staphylococcus aureus growing in biofilms.
    The Journal of antimicrobial chemotherapy, 2013, Volume: 68, Issue:8

    Topics: Anti-Bacterial Agents; Bacterial Load; Biofilms; Cytokinesis; Gene Expression Profiling; Microbial Viability; Staphylococcus aureus; Vancomycin; Virginiamycin

2013
Which antibiotic for hospital acquired pneumonia caused by MRSA?
    BMJ (Clinical research ed.), 2014, Feb-13, Volume: 348

    Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Cross Infection; Daptomycin; Humans; Linezolid; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Minocycline; Oxazolidinones; Pneumonia, Staphylococcal; Tigecycline; Vancomycin; Virginiamycin

2014
Antimicrobial susceptibility pattern of vancomycin resistant enterococci to newer antimicrobial agents.
    The Indian journal of medical research, 2015, Volume: 141, Issue:4

    Topics: Anti-Infective Agents; Daptomycin; Humans; Linezolid; Minocycline; Tigecycline; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci; Virginiamycin

2015
Susceptibility Profile of Staphylococcus epidermidis and Staphylococcus haemolyticus Isolated from Blood Cultures to Vancomycin and Novel Antimicrobial Drugs over a Period of 12 Years.
    Microbial drug resistance (Larchmont, N.Y.), 2016, Volume: 22, Issue:4

    Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; Blood Culture; Brazil; Daptomycin; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Gene Expression; Hospitals, Teaching; Humans; Linezolid; Minocycline; Mutation; Oxacillin; Prevalence; Staphylococcal Infections; Staphylococcus epidermidis; Staphylococcus haemolyticus; Tigecycline; Vancomycin; Virginiamycin

2016
Antimicrobial resistance of Staphylococcus aureus isolated from skin infections and its implications in various clinical conditions in Korea.
    International journal of dermatology, 2016, Volume: 55, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxacin; Clindamycin; Dibekacin; Drug Resistance, Multiple, Bacterial; Erythromycin; Female; Fusidic Acid; Gentamicins; Humans; Infant; Infant, Newborn; Ketolides; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Mupirocin; Oxacillin; Republic of Korea; Retrospective Studies; Rifampin; Staphylococcal Skin Infections; Staphylococcus aureus; Teicoplanin; Tetracycline; Vancomycin; Virginiamycin; Young Adult

2016
Mechanism of action of a novel recombinant peptide, MP1102, against Clostridium perfringens type C.
    Applied microbiology and biotechnology, 2016, Volume: 100, Issue:11

    Topics: Ampicillin; Anti-Bacterial Agents; Cell Membrane; Chlortetracycline; Clostridium perfringens; DNA, Bacterial; Drug Synergism; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Nisin; Recombinant Proteins; Temperature; Vancomycin; Virginiamycin; Zinc

2016
Characteristic of Enterococcus faecium clinical isolates with quinupristin/dalfopristin resistance in China.
    BMC microbiology, 2016, 10-21, Volume: 16, Issue:1

    Topics: Anti-Bacterial Agents; Bacterial Proteins; China; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Genes, Bacterial; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Prevalence; RNA, Ribosomal, 16S; Vancomycin; Virginiamycin

2016
Influence of sublethal concentrations of vancomycin and quinupristin/dalfopristin on the persistence of viable but non-culturable Staphylococcus aureus growing in biofilms.
    The Journal of antimicrobial chemotherapy, 2018, 12-01, Volume: 73, Issue:12

    Topics: Anti-Bacterial Agents; Bacterial Load; Biofilms; Gene Expression Profiling; Microbial Viability; Staphylococcus aureus; Vancomycin; Virginiamycin

2018
Evaluation of the Presence and Characterization of Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Level Resistance Among Bloodstream Isolates of Methicillin-Resistant
    Microbial drug resistance (Larchmont, N.Y.), 2020, Volume: 26, Issue:3

    Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Typing Techniques; Ceftaroline; Cephalosporins; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Gene Expression; Genes, Bacterial; Humans; Linezolid; Methicillin; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Phylogeny; Rifampin; Staphylococcal Infections; Tetracycline; Turkey; Vancomycin; Vancomycin Resistance; Virginiamycin

2020
Antimicrobial susceptibility of bacteremic vancomycin-resistant Enterococcus faecium to eravacycline, omadacycline, lipoglycopeptides, and other comparator antibiotics: Results from the 2019-2020 Nationwide Surveillance of Multicenter Antimicrobial Resist
    International journal of antimicrobial agents, 2021, Volume: 58, Issue:1

    Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Daptomycin; Drug Resistance, Bacterial; Enterococcus faecium; Epidemiological Monitoring; Gram-Positive Bacterial Infections; Humans; Linezolid; Lipoglycopeptides; Microbial Sensitivity Tests; Oxazolidinones; Taiwan; Tetracyclines; Tetrazoles; Tigecycline; Vancomycin; Vancomycin-Resistant Enterococci; Virginiamycin

2021